Aciphex New Drug Of Choice For Acid Reflux Disease

by Train Crossroad on 02/07/10 at 12:13 pm

Aciphex New Drug Of Choice For Acid Reflux DiseaseAcid Reflux or also known as gastroesophageal reflux disease is mucosal damage. A common symptom is heartburn and can happen with both adults and children. This disease is a very painful and also dangerous as well. Symptoms of this disease includes heartburn, regurgitation and trouble swallowing for adults. While for children, even though it is really hard to detect acid reflux in children, symptoms includes vomiting and coughing. Only recently, molecular imaging may have found out the cause of the acid reflux disease. They have found out evidence that the disease if caused by a lack of tone or motility in the muscles that help keep stomach acids or other content from going into esophagus.

By knowing the cause of acid reflux disease, we will be able to attempt to prevent this disease. Since this illness affects a pretty big chunk of the population, preventing this disease is very important to just about everyone. Slowly we are able to learn more about this disease and will be able to help about 15% of the general population that have this disease. Since this disease is found out in 15% of the general population, finding out the actual cause is indeed important. Now that with molecular imaging they have some more idea of what the cause may be, they can work harder to make sure this is the actual cause. Once they have found the actual cause and a way to prevent it. We may see the number of people with acid reflux decrease greatly and the people that have this disease will be treated and gotten rid of this painful illness. Also, with this molecular imaging that might have found the cause, the FDA has accepted the new drug for treating acid reflux disease.

This new drug is rabeprazole sodium extended-release 50mg and it is used for healing acid reflux disease. This is also known as ACIPHEX. This new drug is a prescription medication and it is used once daily for adults. ACIPHEX will be used for symptom relief. This is used for a short amount of time since it has not been tested for treatments that last more than a year. This is mainly used for short treatment for heartburn symptoms because it truly is painful. However for children under 12, both the safety and effectiveness of ACIPHEX has not been said. ACIPHEX, like most drugs, have side effects and this includes headache, diarrhea and some more. With both the imaging that determines the cause of reflux disease and this new ACIPHEX that allows people to treat their symptoms so that acid reflux can be less painful, we are slowly advancing to treat acid reflux for everyone.

Soon the portion of the population that has acid reflux will be able to live their lives more normally like they did without acid reflux. Sometime in the future, better medicine and treatment will be created to treat acid reflux and all of its symptoms. Soon 15% of the population will be relieved of this illness with the help of all the doctors and scientist working hard.

Popularity: 43% [?]

No related posts.

Leave a Reply



WordPress SEO fine-tune by Meta SEO Pack from Poradnik Webmastera
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